Your browser doesn't support javascript.
loading
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.
Holman, Rury R; Bethel, Mary A; Chan, Juliana C N; Chiasson, Jean-Louis; Doran, Zoë; Ge, Junbo; Gerstein, Hertzel; Huo, Yong; McMurray, John J; Ryden, Lars; Liyanage, Winitha; Schröder, Stefan; Tendera, Michal; Theodorakis, Michael J; Tuomilehto, Jaakko; Yang, Wenying; Hu, Dayi; Pan, Changyu.
Afiliação
  • Holman RR; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom. Electronic address: rury.holman@dtu.ox.ac.uk.
  • Bethel MA; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.
  • Chan JC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
  • Chiasson JL; CRCHUM, Department of Medicine, University of Montreal, Montreal, Canada.
  • Doran Z; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.
  • Ge J; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Gerstein H; Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Huo Y; Department of Cardiology, Peking University First Hospital, Beijing, China.
  • McMurray JJ; Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Ryden L; Cardiology Unit, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Liyanage W; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.
  • Schröder S; Bayer Healthcare, Bayer Pharma AG, Berlin, Germany.
  • Tendera M; 3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland.
  • Theodorakis MJ; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.
  • Tuomilehto J; Centre for Vascular Prevention, Danube-University Krems, Krems, Austria; Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; King Abdulaziz University, Jeddah, Saudi Arabia.
  • Yang W; China-Japan Friendship Hospital, Beijing, China.
  • Hu D; People's Hospital of Peking University, Beijing, China.
  • Pan C; Department of Endocrinology, People's Liberation Army General Hospital, Beijing, China.
Am Heart J ; 168(1): 23-9.e2, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24952856
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Glicemia / Intolerância à Glucose / Doença das Coronárias / Acarbose / Diabetes Mellitus Tipo 2 / Prevenção Secundária Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am Heart J Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Glicemia / Intolerância à Glucose / Doença das Coronárias / Acarbose / Diabetes Mellitus Tipo 2 / Prevenção Secundária Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am Heart J Ano de publicação: 2014 Tipo de documento: Article